Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead/Galapagos, Intercept and Corbus trials could be hit by coronavirus spread: analyst
Fierce Biotech
Wed, 03/11/20 - 10:54 am
Tags:
clinical trials, Gilead Sciences, Galapagos, Corbus Pharmaceuticals, Intercept Pharmaceuticals, coronaviruses, COVID-19
Gilead's Descovy not worth the higher price over forthcoming Truvada generics: study
Fierce Pharma
Tue, 03/10/20 - 10:50 am
Tags:
Gilead Sciences, Descovy, Truvada, HIV, drug pricing
Will Gilead Sciences Make a Fortune Off Its Coronavirus Drug?
Motley Fool
Mon, 03/9/20 - 10:45 am
Tags:
Gilead Sciences, remdesivir, coronaviruses, COVID-19, drug repurposing
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
Marketwatch
Sun, 03/8/20 - 11:26 pm
Tags:
Gilead Sciences, GSK, Innovio, JNJ, Moderna Therapeutics, Regeneron, Sanofi, Takeda, Vir Biotchnology
Gilead strikes $4.9B Forty Seven acquisition, paying a hefty premium for cancer drug
Fierce Biotech
Mon, 03/2/20 - 10:13 am
Tags:
Gilead Sciences, M&A, Forty Seven, CD-47
Morphosys’ off-the-shelf rival to CAR-T approaches finish line with a speedy review
Endpoints
Mon, 03/2/20 - 09:37 am
Tags:
MorphoSys, Gilead Sciences, Novartis, CAR-T, tafasitamab, DLBCL
2 Biotech Stocks Winning The Coronavirus Race
Motley Fool
Sun, 03/1/20 - 07:58 pm
Tags:
Gilead Sciences, Moderna Therapeutics, COVID-19, coronaviruses
Gilead hungry for 'don't eat me' cancer biotech: reports
Fierce Biotech
Fri, 02/28/20 - 10:51 am
Tags:
Gilead Sciences, Forty Seven, cancer, M&A
Pharmacquired: Where are all the deals?
BioPharma Dive
Thu, 02/27/20 - 10:46 am
Tags:
M&A, Gilead Sciences, Biogen, Sanofi, Eli Lilly, GSK, Merck, Vertex Pharmaceuticals
Gilead commits to own development of coronavirus treatment hopeful
BioPharma Dive
Thu, 02/27/20 - 10:36 am
Tags:
Gilead Sciences, remdesivir, clinical trials, coronaviruses, COVID-19
Gilead Antiviral Drug Shows the Most Potential for COVID-19, Says WHO Official
Motley Fool
Tue, 02/25/20 - 12:06 am
Tags:
Gilead Sciences, coronavirus, COVID-19, WHO, antivirals, China, remdesivir
Where Will Gilead Sciences Be in 10 Years?
Motley Fool
Sat, 02/22/20 - 11:23 pm
Tags:
Gilead Sciences, HIV, hepatitis C
Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court
Fierce Pharma
Fri, 02/21/20 - 10:39 am
Tags:
Gilead Sciences, PrEP, HHS, patents, HIV
Upcoming events – Filgotinib's ulcerative colitis data and serlopitant takes on pruritus
EP Vantage
Fri, 02/21/20 - 10:35 am
Tags:
Gilead Sciences, Galapagos, filgotinib, ulcerative colitis, Menlo Therapeutics, serlopitant
Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?
Pharmaforum
Fri, 02/21/20 - 10:31 am
Tags:
China, Gilead Sciences, Sovaldi, COVID-19, coronaviruses
Gilead Struggles to Recruit Patients for Coronavirus Drug Trial in China
BioSpace
Tue, 02/18/20 - 10:57 am
Tags:
Gilead Sciences, remdesivir, clinical trials, China, COVID-19
China approves flu drug being touted as a potential coronavirus treatment amid a rush of clinical studies
Endpoints
Tue, 02/18/20 - 10:31 am
Tags:
China, COVID-19, coronaviruses, fapilavir, Gilead Sciences
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
Tags:
drug launches, Biohaven, rimegepant, Novartis, ofatumumab, Celgene, ozanimod, Akebia Therapeutics, vadadustat, Biomarin, valrox, Gilead Sciences, filgotinib, Novo Nordisk, oral semaglutide, inclisiran, Immunomedics, sacituzumab govitecan, AstraZeneca, Enhertu, Bristol-Myers Squibb, liso-cel
Chinese firm copycats Gilead's remdesivir, the most promising drug against the new coronavirus
Fierce Pharma
Wed, 02/12/20 - 10:57 am
Tags:
China, coronavirus, COVID-19, remdesivir, Gilead Sciences, patents, BrightGene
Is Gilead Sciences an Acquisition Target?
Motley Fool
Tue, 02/11/20 - 11:38 pm
Tags:
Gilead Sciences, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.